The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Ibandronic Acid Liconsa 150 mg Film-Coated Tablets

150 milligram(s) Film-coated tablet

Laboratorios LICONSA, S.A.PA1239/013/001

Main Information

Trade NameIbandronic Acid Liconsa 150 mg Film-Coated Tablets
Active SubstancesIbandronic acid
Strength150 milligram(s)
Dosage FormFilm-coated tablet
Licence HolderLaboratorios LICONSA, S.A.
Licence NumberPA1239/013/001

Group Information

ATC CodeM05BA Bisphosphonates
M05BA06 ibandronic acid


Withdrawn Date10/12/2019
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back